Encouraging Innovation and Risk Taking

Genentech

In this clip, STVP Executive Director Tina Seelig asks Genentech Executive Vice President Richard Scheller to explain how he encourages his team to innovate in the face of financial risks. As the head of Genentech's research and early development, Scheller accepts failure as part of the process. He also describes how the company mitigates risk by maintaining a balanced portfolio of products, with each drug in the portfolio measured by commercial value and probable technical success.